Kling Douglas F
Chief Operating Officer · 9 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025-07-16 | NAMS | NewAmsterdam Pharma Co N.V. | Sale | 51,043 | $21.10 | $1.1M | filing |
| 2025-07-16 | NAMS | NewAmsterdam Pharma Co N.V. | Option exercise | 51,043 | $10.90 | $556,368.70 | filing |
| 2025-07-15 | NAMS | NewAmsterdam Pharma Co N.V. | Sale | 44,025 | $21.38 | $941,254.50 | filing |
| 2025-07-15 | NAMS | NewAmsterdam Pharma Co N.V. | Option exercise | 47,569 | $10.90 | $518,502.10 | filing |
| 2025-07-15 | NAMS | NewAmsterdam Pharma Co N.V. | Sale | 3,544 | $22.12 | $78,393.28 | filing |
| 2025-06-16 | NAMS | NewAmsterdam Pharma Co N.V. | Sale | 81,891 | $19.19 | $1.6M | filing |
| 2025-06-16 | NAMS | NewAmsterdam Pharma Co N.V. | Option exercise | 78,101 | $10.00 | $781,010.00 | filing |
| 2025-06-16 | NAMS | NewAmsterdam Pharma Co N.V. | Sale | 18,109 | $19.75 | $357,652.75 | filing |
| 2025-06-16 | NAMS | NewAmsterdam Pharma Co N.V. | Option exercise | 21,899 | $10.90 | $238,699.10 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.